Home LiteratureArticle Details
PMID: 18528739 Published · ppublish English Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Hypoxia markers in human osteosarcoma: an exploratory study.

Clinical orthopaedics and related research ·Vol. 466 ·No. 9 ·2008-09-00 ·Pages 2052-9

Mizobuchi H, García-Castellano JM, Philip S, Healey JH, Gorlick R

Abstract

Neoplastic cells growing under hypoxic conditions exhibit a more aggressive phenotype by activating a cascade of molecular events partly mediated by hypoxia-inducible transcription factor (HIF-1alpha) and vascular endothelial growth factor (VEGF). The roles of these markers have been studied previously in several cancer lines. We ascertained the frequency of HIF-1alpha expression, VEGF expression, the degree of neovascularization, and cell proliferation in osteosarcoma samples. Samples from osteosarcoma patients were assessed for HIF-1alpha and VEGF protein expression using immunohistochemistry, neovascularization using antibodies for Factor VIII, and cell proliferation using the Ki-67 labeling index. Associations between these parameters and clinical features were examined. HIF-1alpha staining was positive in 35% of patients and metastases were present in 61% of these HIF-1alpha-positive patients. VEGF protein expression was detected in 69% of patients, 92% of whom were female. We observed an insignificant trend for a higher frequency of VEGF expression in the high-grade as compared to low-grade osteosarcoma. We observed no association between vascular density and proliferation index and any clinical parameters. We found an association between HIF-1alpha expression and metastatic disease and between VEGF expression and female gender.

MeSH Terms
Adolescent Adult Biomarkers, Tumor/metabolism Bone Neoplasms/metabolism,pathology Cell Proliferation Child Female Femoral Neoplasms/metabolism,pathology Gene Expression Regulation, Neoplastic/physiology Humans Hypoxia/metabolism Hypoxia-Inducible Factor 1, alpha Subunit/metabolism Immunohistochemistry Ki-67 Antigen/metabolism Male Osteosarcoma/metabolism,pathology Sex Factors Tibia Vascular Endothelial Growth Factor A/metabolism
Chemicals
Biomarkers, Tumor Hypoxia-Inducible Factor 1, alpha Subunit Ki-67 Antigen Vascular Endothelial Growth Factor A
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Mizobuchi Hiroo
Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
García-Castellano José Manuel
Philip Shaji
Healey John H
Gorlick Richard
References (51)
51 references, click to expand
  1. The labelling index in carcinoma of the uterine cervix: its correlation with tumour sterilization.
    Br J Radiol. 1992 Jan;65(769):63-5 PMID: 1486370
  2. Oxygenation predicts radiation response and survival in patients with cervix cancer.
    Radiother Oncol. 1998 Aug;48(2):149-56 PMID: 9783886
  3. Preoperative chemotherapy for osteogenic sarcoma: selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy.
    Cancer. 1982 Mar 15;49(6):1221-30 PMID: 6174200
  4. [Therapeutic effects of RNA interference targeting HIF-1 alpha gene on human osteosarcoma].
    Zhonghua Yi Xue Za Zhi. 2005 Feb 16;85(6):409-13 PMID: 15854533
  5. Carcinoma of the cervix uteri: an assessment of the relationship of tumour proliferation to prognosis.
    Br J Cancer. 1992 May;65(5):783-5 PMID: 1586610
  6. Conversion of alpha-helices into beta-sheets features in the formation of the scrapie prion proteins.
    Proc Natl Acad Sci U S A. 1993 Dec 1;90(23):10962-6 PMID: 7902575
  7. Hypoxia in cancer: significance and impact on clinical outcome.
    Cancer Metastasis Rev. 2007 Jun;26(2):225-39 PMID: 17440684
  8. Histological and immunohistochemical prediction for local control of cervical squamous cell carcinoma treated with radiotherapy alone.
    Int J Radiat Oncol Biol Phys. 1990 Oct;19(4):1011-9 PMID: 2211239
  9. Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review.
    Cancer Res. 1989 Dec 1;49(23):6449-65 PMID: 2684393
  10. Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases.
    Cancer Res. 1999 Nov 15;59(22):5830-5 PMID: 10582706
  11. Hypoxia-inducible factor-1alpha is associated with risk of aggressive behavior and tumor angiogenesis in gastrointestinal stromal tumor.
    Jpn J Clin Oncol. 2005 Apr;35(4):207-13 PMID: 15845570
  12. Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix.
    Cancer Res. 1996 Oct 1;56(19):4509-15 PMID: 8813149
  13. Expression of hypoxia-inducible factor-1alpha and cell cycle proteins in invasive breast cancer are estrogen receptor related.
    Breast Cancer Res. 2004;6(4):R450-9 PMID: 15217513
  14. Intratumoral pO2 predicts survival in advanced cancer of the uterine cervix.
    Radiother Oncol. 1993 Jan;26(1):45-50 PMID: 8438086
  15. Vascular endothelial growth factor, wild-type p53, and angiogenesis in early operable non-small cell lung cancer.
    Clin Cancer Res. 1998 Dec;4(12):3017-24 PMID: 9865915
  16. Prediction of radiotherapy response of cervical carcinoma through measurement of proliferation rate.
    Br J Cancer. 1996 Oct;74(8):1223-6 PMID: 8883408
  17. Clinical implications of circulating angiogenic factors in cancer patients.
    J Clin Oncol. 2001 Feb 15;19(4):1207-25 PMID: 11181687
  18. Regulation of vascular endothelial growth factor (VEGF) gene transcription by estrogen receptors alpha and beta.
    Proc Natl Acad Sci U S A. 2000 Sep 26;97(20):10972-7 PMID: 10995484
  19. Tumour proliferation and apoptosis in human uterine cervix carcinoma II: correlations with clinical outcome.
    Radiother Oncol. 1999 Jan;50(1):93-101 PMID: 10225562
  20. Interrelationship of proliferation and hypoxia in carcinoma of the cervix.
    Int J Radiat Oncol Biol Phys. 2000 Jan 1;46(1):95-9 PMID: 10656379
  21. A unitary model for involutional osteoporosis: estrogen deficiency causes both type I and type II osteoporosis in postmenopausal women and contributes to bone loss in aging men.
    J Bone Miner Res. 1998 May;13(5):763-73 PMID: 9610739
  22. VEGF and the quest for tumour angiogenesis factors.
    Nat Rev Cancer. 2002 Oct;2(10):795-803 PMID: 12360282
  23. Candidate genes for the hypoxic tumor phenotype.
    Cancer Res. 2000 Feb 15;60(4):883-7 PMID: 10706099
  24. Clinicopathological and immunohistochemical analysis of twenty-five head and neck osteosarcomas.
    Oral Oncol. 2003 Jul;39(5):521-30 PMID: 12747978
  25. Sex steroids and bone.
    Recent Prog Horm Res. 2002;57:385-409 PMID: 12017554
  26. Cells at intermediate oxygen levels can be more important than the "hypoxic fraction" in determining tumor response to fractionated radiotherapy.
    Radiat Res. 1997 May;147(5):541-50 PMID: 9146699
  27. Hypoxia-induced metastasis of human melanoma cells: involvement of vascular endothelial growth factor-mediated angiogenesis.
    Br J Cancer. 1999 Aug;80(11):1697-707 PMID: 10468285
  28. Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours.
    Nature. 1996 Jan 4;379(6560):88-91 PMID: 8538748
  29. Expression of cyclooxygenase-2 (COX-2), receptors for estrogen (ER), and progesterone (PR), p53, ki67, and neu protein in endometrial cancer.
    Gynecol Oncol. 2005 Sep;98(3):383-9 PMID: 15979129
  30. Identification of novel small molecule inhibitors of hypoxia-inducible factor-1 that differentially block hypoxia-inducible factor-1 activity and hypoxia-inducible factor-1alpha induction in response to hypoxic stress and growth factors.
    Cancer Res. 2005 Jun 1;65(11):4918-28 PMID: 15930314
  31. Gene expression of vascular endothelial growth factor in giant cell tumors of bone.
    Hum Pathol. 2000 Jul;31(7):804-12 PMID: 10923916
  32. The human hypoxia-inducible factor 1alpha gene: HIF1A structure and evolutionary conservation.
    Genomics. 1998 Sep 1;52(2):159-65 PMID: 9782081
  33. Cyclooxygenase 2: a molecular target for cancer prevention and treatment.
    Trends Pharmacol Sci. 2003 Feb;24(2):96-102 PMID: 12559775
  34. Vascular endothelial growth factor expression in untreated osteosarcoma is predictive of pulmonary metastasis and poor prognosis.
    Clin Cancer Res. 2000 Feb;6(2):572-7 PMID: 10690541
  35. Regulation of mammalian O2 homeostasis by hypoxia-inducible factor 1.
    Annu Rev Cell Dev Biol. 1999;15:551-78 PMID: 10611972
  36. Tumor proliferation in rectal cancer following preoperative irradiation.
    J Clin Oncol. 1995 Jun;13(6):1417-24 PMID: 7751887
  37. Proliferation measurements with flow cytometry Tpot in cancer of the uterine cervix: correlation between two laboratories and preliminary clinical results.
    Int J Radiat Oncol Biol Phys. 1995 Jul 30;32(5):1319-29 PMID: 7635771
  38. [Vascular endothelial growth factor expression and microvessel density in stage I-II non-small cell lung cancer and their prognostic significances].
    Ai Zheng. 2005 Jul;24(7):865-9 PMID: 16004817
  39. Sex steroids and the construction and conservation of the adult skeleton.
    Endocr Rev. 2002 Jun;23(3):279-302 PMID: 12050121
  40. New insight into the transcriptional regulation of vascular endothelial growth factor expression in the endometrium by estrogen and relaxin.
    Ann N Y Acad Sci. 2005 May;1041:233-47 PMID: 15956714
  41. COX-2 expression in DCIS: correlation with VEGF, HER-2/neu, prognostic molecular markers and clinicopathological features.
    Histopathology. 2005 May;46(5):561-8 PMID: 15842638
  42. [Effect of silencing HIF-1alpha by RNA interference on expression of vascular endothelial growth factor in osteosarcoma cell line SaOS-2 under hypoxia].
    Ai Zheng. 2005 May;24(5):531-5 PMID: 15890092
  43. Invasive lobular and invasive ductal carcinoma of the breast show distinct patterns of vascular endothelial growth factor expression and angiogenesis.
    J Pathol. 1998 Aug;185(4):394-401 PMID: 9828838
  44. Vascular permeability factor, an endothelial cell mitogen related to PDGF.
    Science. 1989 Dec 8;246(4935):1309-12 PMID: 2479987
  45. Effect of etoposide, carmustine, vincristine, 5-fluorouracil, or methotrexate on radiobiologically oxic and hypoxic cells in a C3H mouse mammary carcinoma in situ.
    Cancer Chemother Pharmacol. 1992;30(4):277-80 PMID: 1643695
  46. Identification of a novel small-molecule inhibitor of the hypoxia-inducible factor 1 pathway.
    Cancer Res. 2005 Jan 15;65(2):605-12 PMID: 15695405
  47. Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis.
    Endocr Rev. 2000 Apr;21(2):115-37 PMID: 10782361
  48. High-level expression of angiogenic factors is associated with advanced tumor stage in human neuroblastomas.
    Clin Cancer Res. 2000 May;6(5):1900-8 PMID: 10815914
  49. [Expressions of CD44s, MMP-9, and Ki-67: possible association with invasion, metastasis, and recurrence of osteosarcoma].
    Ai Zheng. 2002 Jul;21(7):745-50 PMID: 12479099
  50. Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects.
    J Natl Cancer Inst. 2001 Feb 21;93(4):266-76 PMID: 11181773
  51. Cell-retained isoforms of vascular endothelial growth factor (VEGF) are correlated with poor prognosis in osteosarcoma.
    Eur J Cancer. 1999 Jul;35(7):1089-93 PMID: 10533453
Article Info
Journal
Clinical orthopaedics and related research
Abbr.
Clin Orthop Relat Res
ISSN
1528-1132
Published
2008-09-00
Epub
2008-00-05
Pages
2052-9
Language
English
Region
United States
NLM ID
0075674
PMCID
PMC2493019
Subset
IM
Grants
NCI NIH HHS · R01 CA083132 · United States
NCI NIH HHS · R01 CA 83132 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com